Use the collections feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up
Collections
DM HTN and CVD Risk and Therap...
DM HTN and CVD Risk and Therapy
• Articles Related to HTN DM and CVD Risks
#1
RANDOMIZED CONTROLLED TRIAL
Subodh Verma, C David Mazer, Andrew T Yan, Tamique Mason, Vinay Garg, Hwee Teoh, Fei Zuo, Adrian Quan, Michael E Farkouh, David H Fitchett, Shaun G Goodman, Ronald M Goldenberg, Mohammed Al-Omran, Richard E Gilbert, Deepak L Bhatt, Lawrence A Leiter, Peter Jüni, Bernard Zinman, Kim A Connelly
BACKGROUND: SGLT2 (sodium-glucose cotransporter 2) inhibitors lower cardiovascular events in type 2 diabetes mellitus but whether they promote direct cardiac effects remains unknown. We sought to determine if empagliflozin causes a decrease in left ventricular (LV) mass in people with type 2 diabetes mellitus and coronary artery disease. METHODS: Between November 2016 and April 2018, we recruited 97 individuals ≥40 and ≤80 years old with glycated hemoglobin 6...
November 19, 2019: Circulation
#2
JOURNAL ARTICLE
Khagendra Dahal, Aditya Hendrani, Sharan P Sharma, Sampath Singireddy, George Mina, Pratap Reddy, Paari Dominic, Kalgi Modi
Importance: Treatment with aldosterone antagonists is recommended and has been shown to have beneficial effects in patients with ST-segment elevation myocardial infarction (STEMI) and left ventricular ejection fraction (LVEF) less than 40%. However, the role of aldosterone antagonists in patients with ejection fraction greater than 40% or without congestive heart failure is not well known. Objectives: To perform a systematic review and meta-analysis using standard techniques to determine the role of therapy with aldosterone antagonists in this patient population...
July 1, 2018: JAMA Internal Medicine
#3
EDITORIAL
Kenneth A Jamerson
No abstract text is available yet for this article.
April 30, 2019: Circulation
1
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
